You may not be able to visit this page because of:
Please try one of the following pages:
If difficulties persist, please contact the System Administrator of this site.
Component not found
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial best place to buy viagra online brand viagra without prescription online restoring nNOS protein within the PVN of diabetic rats with viral gene transfer could alleviate the blunted NMDA induced erectile responses. Tens of millions of men worldwide have benefited from oral ED medications such as sildenafil (Viagra), vardenafil (Levitra), and tadalafil (Cialis). However, these medications which belong to a class of drugs called phosphodiesterase type 5 (PDE5) inhibitors have limitations. They can cause systemic side effects that can be serious. These side effects include headache, facial flushing, nasal congestion, upset stomach, abnormal vision as well as isolated reports of hearing and vision loss. Men who've recently suffered a heart attack or stroke or have severe heart disease should use these drugs with caution or not at all. In addition, "an estimated 30 to 50 percent of men with ED do not respond to oral use of PDE5 inhibitors," says senior author Kelvin P. Davies, Ph.D., associate professor of urology at Einstein. where to buy viagra viagra for sale online canada Erectile dysfunction, also known as impotence, has many causes and a growing body of treatments. According to the National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC), erectile dysfunction "can be a total inability to achieve erection, an inconsistent ability to do so, or a tendency to sustain only brief erections." The condition affects as many as 30 million American men at some point in their lives. From the Internal Medicine Unit, IRCCS Maugeri Foundation Hospital, Department of Internal Medicine and Medical Therapeutics (C.G., S.G., E.D.A., G.B., P.F.), Cardiology Unit (C.F.), Internal Medicine, Vascular and Metabolic Diseases, IRCCS Policlinico San Matteo (D.G.), and the Department of Internal Medicine and Medical Therapeutics (S.B.S.), University of Pavia; and Diabetes Centers of Pavia and Mede (A.G.), Azienda Ospedaliera Province of Pavia, Pavia, Italy.